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Despite considerable excitement over the potential functional signiﬁcance of copy-number variants (CNVs), we still lack knowledge of
the ﬁne-scale architecture of the large majority of CNV regions in the human genome. In this study, we used a high-resolution array-
based comparative genomic hybridization (aCGH) platform that targeted known CNV regions of the human genome at approximately
1 kb resolution to interrogate the genomic DNAs of 30 individuals from four HapMap populations. Our results revealed that 1020
of 1153 CNV loci (88%) were actually smaller in size than what is recorded in the Database of Genomic Variants based on previously
published studies. A reduction in size of more than 50% was observed for 876 CNV regions (76%). We conclude that the total genomic
content of currently known common humanCNVs is likely smaller than previously thought. In addition, approximately 8% of the CNV
regions observed inmultiple individuals exhibited genomic architectural complexity in the form of smaller CNVs within larger ones and
CNVs with interindividual variation in breakpoints. Future association studies that aim to capture the potential inﬂuences of CNVs on
disease phenotypes will need to consider how to best ascertain this previously uncharacterized complexity.Introduction
Genomic DNA copy-number gains and losses have been
studied for more than 30 years (e.g., at the a- and b-glo-
bin [MIM 141800 and 149100],1–3 opsin [MIM 303800],4
and a handful of other gene loci5–9). However, it was gen-
erally assumed that such genomic imbalances were few in
number and had relatively limited impact on the total
content of human genetic variation. Now, recent devel-
opments and applications of genome-wide structural-var-
iation technologies have led to the identiﬁcation of thou-
sands of heritable copy-number variants (CNVs) and
sparked considerable interest.10–19 In part, this interest
has been motivated by observations that CNVs can inﬂu-
ence transcriptional or translational levels of overlapping
or nearby genes15,20–25 and by initial reports that certain
CNVs are associated with differential susceptibility to
complex diseases.22,26–31 However, our ability to expand
on these observations and understand better the func-
tional signiﬁcance of human CNVs is hindered consider-
ably by our limited knowledge of their ﬁne-scale archi-
tecture. To simultaneously characterize the ﬁne-scale
architecture of thousands of CNV regions across multiple
individuals, we have constructed a high-density com-
parative genomic hybridization microarray with 470,163
oligonucleotide probes covering 2191 putative CNV re-
gions with approximately 1 kb spacing and used this
array to interrogate the genomic DNAs of 30 HapMap
individuals.32The AMaterial and Methods
Microarray Design
Wedesigneda two-chip array-based comparative genomichybridiza-
tion (aCGH) set containing 470,163 60-mer oligonucleotide probes
(Agilent Technologies, Santa Clara, CA),33 including 444,891 probes
withapproximately1kb spacing through2191putativeCNVregions
thatwereannotated intheDatabaseofGenomicVariants asof30No-
vember2006, and their ﬂanking regions (approximately1 kb spacing
for5kbupstreamanddownstream,withprogressively reducedprobe
density for an additional 15 kb). Probe sequences were based on the
human genome reference sequence (hg17). In order to sufﬁciently
cover segmental duplications (SDs),34 which are commonly associ-
ated with CNVs (e.g.,35), we allowed probes to have multiple perfect
matcheswithin thehumangenome reference assembly (hg17)when
unique probes were not available at the desired density. The probes
for chromosomes 1, 4, 5, 7, 11, 13, 15, 16, 17, 18, 19, and 21were as-
signed to array A, and probes for the remaining chromosomes were
assigned to array B. We also selected 23,804 autosomal and 1198 X
chromosomeprobes fromnon-CNVregions throughout the genome
fromAgilent’s High-Deﬁnition database of 8.4million aCGH probes
that cover exonic, intronic, and intergenic regions and have unique
representation in the human genome reference sequence (hg17). Of
these autosomal probes, 19,008 were distributed to arrays A and B
according to chromosome (as described above). A subset of the
non-CNV probes (4796 autosomal probes and the 1198 X chromo-
some probes) was included on both arrays.
DNA-Sample Labeling and Hybridization
Human DNA samples were selected from the four populations of
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unrelated Yoruba individuals from Ibadan, Nigeria (YRI), ten un-
related European-American individuals from Utah (CEPH), ﬁve
unrelated Japanese individuals from Tokyo, and ﬁve unrelated
Chinese individuals from Beijing. For analyses, we considered
the Japanese and Chinese samples as one Asian population
(ASN). Samples were selected from those thought to be absent of
detectable cell-line artifacts, on the basis of karyotype and compu-
tational analyses.16 A single reference sample (NA10851, a CEPH
male) was used for all aCGH experiments. This individual was
also used as the common reference sample in a previous ge-
nome-wide study of copy number variation in the HapMap popu-
lation samples.16 This facilitated direct comparisons between the
two datasets. Genomic DNAs were isolated from B lymphoblastoid
cell lines obtained from the Coriell Institute for Medical Research
(Camden, NJ) with the Puregene DNA Puriﬁcation Kit (Gentra
Systems, Minneapolis, MN).
aCGH experiments were performed according to the manufac-
turer’s instructions. In brief, test and reference genomic DNAs
(500 ng) were digested with restriction enzymes AluI and RsaI
and ﬂuorescently labeled with Cy5 (test) and Cy3 (reference)
with the Agilent DNA Labeling Kit. For each sample, duplicate la-
beling reactions were mixed and then separated prior to hybridiz-
ing to each of the two arrays. Labeled test and reference DNAswere
combined, denatured, pre-annealed with Cot-1 DNA (Invitrogen,
Carlsbad, CA) and blocking reagent (Agilent), and then hybridized
to the arrays for 40 hr in a rotating oven (Agilent Technologies) at
65C and 20 rpm. Dye-swap experiments (test in Cy3 and refer-
ence in Cy5) were performed for each sample. After hybridization
and recommended washes, the arrays were scanned at 5 mm reso-
lution with an Agilent G2505A scanner. Images were analyzed
with Feature Extraction Software 9.1.1.1 (Agilent Technologies),
with the CGH-v4_91 protocol for background subtraction and
normalization. All array data passed Agilent recommended quality
metrics. The array data have been submitted to the Gene Expres-
sion Omnibus under accession number GSE9831.
Algorithm for Calling CNVs
We performed a BLAST analysis36 of all probe sequences against
the human genome reference sequence (hg17) to identify all geno-
mic locations with perfect (identical 60 bp) and imperfect (20–59
bp) matches. A total of 512,945 perfect genomic hits were identi-
ﬁed. For CNV calling, all perfect genomic matches were included
for each probe in the analyses, with the following exceptions.
First, to avoid potential sex-linked artifacts, we ignored 5121
probes with a perfect match to an autosome and a perfect or im-
perfect match to either the X or Y chromosome, a perfect match
to either the X or Y chromosome and an imperfect match to an
autosome, or matches to both the X and Y chromosomes. Second,
we ignored probes mapped to the immunoglobulin loci that
might undergo somatic deletion in B lymphoblast cells (hg17:
chr2:88,960,288–89,990,012, chr14:105,030,829–106,300,130, and
chr22:20,778,738–21,600,000). Finally, for some analyses, we have
further restricted the set of probes to those with perfect hits that
are either unique to one location or occur only within 2 Mb of
each other (the ‘‘proximal probe set’’).
Log2 intensity ratio measurements for array A and array B were
merged and analyzed as a single dataset for each experiment. Fea-
tures corresponding to the same probe sequences were averaged
with the weighted averaging method used in CGH Analytics (Agi-
lent Technologies, Santa Clara, CA). For each probe, a single com-
bined log2 ratio was computed as the mean of the values from the
original array and its dye swap. We estimated the sample-speciﬁc686 The American Journal of Human Genetics 82, 685–695, March 2dye bias for each probe as half of the difference between the two
log2 ratios (both computed as test: reference). We also calculated
for each probe the median dye bias across all 30 HapMap experi-
ments and the corresponding interquartile range (IQR). For each
experiment, we ﬂagged and removed any probe with sample-spe-
ciﬁc dye bias that (1) was greater than the absolute value of its
combined log2 ratio and (2) was greater than 2.5 IQR from the
median dye bias. On average, 864 probes were removed per exper-
iment.
We used the ADM2 statistical algorithm37,38 to identify CNVs
on the basis of the combined log2 ratios. In brief, ADM2 uses an
iterative procedure to identify all genomic regions for which the
weighted average of the measured probe signals is different from
the expected value of 0 by more than a given threshold. This de-
viation is measured by a statistical score. Loci with nearby gain
or loss intervals and an intervening region of more than 4 probes
with log2 ratios not different than 0 were considered two separate
CNVs. To select parameters for calling CNVs (i.e., the statistical
threshold of the ADM2 algorithm, the minimum 5 log2 ratio,
and the minimum number of probes in a CNV interval), we itera-
tively called CNVs across all 30 HapMap samples and in three self-
self experiments (NA10851 versus NA10851) for different combi-
nations of these parameters. We estimated the false-positive error
rate for each combination based on the average number of CNV
calls in the self-self experiments divided by the average number
of CNV calls in the HapMap sample experiments. We targeted
a false-positive rate of less than 5%, but without dramatic reduc-
tions in the number of calls in the HapMap sample experiments
(i.e., reducing the false-positive rate to 0 might result in an unac-
ceptably high false-negative rate). By using this approach, we se-
lected the following parameters: statistical threshold ¼ 5.0, mini-
mum 5 log2 ratio ¼ 0.25 (theoretically sufﬁcient to distinguish
six copies versus ﬁve copies; i.e., log2 (6/5) > 0.25), and minimum
number of probes ¼ 2, resulting in averages of 34.3 calls for self-
self experiments and 710 calls for the HapMap sample experi-
ments (estimated false-positive rate¼ 4.8%).We do note, however,
that this comparison might underestimate the true false-positive
rate in our test experiments because the self-self experiments
were performed with genomic DNA from a single extraction and
thus cannot account for minor differences in DNA quality among
our samples. The identiﬁed CNV intervals are reported in Table S1
(using genome-wide perfect match probes) and Table S2 (using the
proximal probe set) available online. CNVs on the X and Y chro-
mosomes are reported for males only. CNV regions were deﬁned
on the basis of the union of all overlapping CNVs across all 30
HapMap individuals (Table S3).
Results
Evaluation of Concordance of Sample-Speciﬁc CNV
Calls with a Previous Study
We used a high-resolution aCGH platform to compare the
genomic DNAs of 30 HapMap individuals to the genomic
DNA of a single reference individual, a European-American
male (NA10851) also from the HapMap study. Approxi-
mately 470,000 oligonucleotide probes were chosen from
2191 previously reported CNV regions throughout the hu-
man genome, for in-depth interrogation of these CNVs.
Among the 30 HapMap individuals, we identiﬁed CNVs
in1153 (53%)of the 2191 regions (Table S4). The remaining008
CNV regions might contain relatively low-frequency CNVs
not present in the 30 individuals sampled in this study.
Alternatively, these could be false positives in the previous
studies or false negatives in our study.
To explore these possibilities, we compared our CNV calls
to those from the Redon et al.16 study that used two ge-
nome-wide platforms (a whole-genome tiling-path aCGH
platform with approximately 27,000 large-insert clones
[WGTP] and an Affymetrix GeneChip array with approxi-
mately 500,000 single-nucleotide polymorphism probes
[500K EA]) to identify CNVs in the same individuals that
we sampled (and for the WGTP platform, using the same
reference individual as in our study). We deﬁned ‘‘high-
conﬁdence’’ CNVs from the Redon et al.16 study as CNV
calls made by both the WGTP and 500K EA platforms in
the same direction (i.e., gain or loss) for the same individ-
ual. There were 269 such high-conﬁdence CNV calls re-
corded among the 30 HapMap individuals. In the present
study, we identiﬁed gains or losses (in the same direction
and individual) for 260 of the 269 high-conﬁdence CNV
calls (97%; based on WGTP breakpoints; Tables S5 and
S6), demonstrating that our measurements have a low
false-negative rate for CNVs that were consistently identi-
ﬁed across multiple platforms. Next, we examined the
CNV calls from Redon et al.16 for the 30 HapMap individ-
uals that were made by only one of the two platforms
(i.e., excluding high-conﬁdence CNV calls). As expected,
we observed a reduced level of concordance: 1564 of
2237 CNV calls made with the WGTP platform (70%)
and 258 of 480 CNV calls made with the 500K EA platform
(54%; Tables S5 and S6) were also considered CNVs in our
study in the same individual and direction.We note that al-
though the WGTP experiments in the Redon et al.16 study
used the same reference individual as our study tomake rel-
ative gain or loss CNV calls, the calls based on the 500K EA
platform were based on average population intensities,
which might in part account for the relatively lower level
of observed concordance with our calls. Finally, on the ba-
sis of CNV call concordance, we were able to identify, with
high accuracy, the samples in our study from all 270 Hap-
Map individuals studied by Redon et al.16 (Figure S1 and
Table S7).
The Total Genomic Content of Common Human
CNVs Might Be Smaller than Previously Thought
We compared the estimated sizes of CNV regions in our da-
taset to estimates from previous studies for the correspond-
ing regions, on the basis of information in the Database of
Genomic Variants (DGV). We found that our estimate of
the total amount of copy-number-variable sequence was
smaller than the corresponding DGV region for 1020 of
the 1153 loci (88%) in which we called CNVs. Strikingly,
the total amount of copy-number-variable sequence was
reduced by more than 50% for 876 regions (76%; of
1153; Figure 1; Tables S3 and S4).
Because the sizes of CNV regions in the DGV repre-
sent the combination of calls from previous studies, weThe Arepeated the analysis with CNV size estimates from the
data of individual studies (Table 1). Although we obtained
similar results for studies employing BAC-based aCGH and
lower-resolution platforms, better size concordance was
observed for studies with potentially increased resolution
(such as Conrad et al.14 and McCarroll et al.15, which
were based on analyses of HapMap SNP genotypes; see
Table 1 for a summary of all comparisons).
We also considered the possibility that in some regions,
we might have actually identiﬁed different and smaller
CNVs than those that were detected by previous lower-res-
olution studies. However, even when we excluded all
regions with less than 20 kb of copy-number-variable
sequence from our dataset and repeated our comparison
with CNVs called by the Redon et al.16 WGTP platform
in the same samples, 213 of 264 overlapping CNVs
(80%) were smaller in our dataset, with 154 of the 264
CNVs (58%) smaller by more than 50% (Figure S2). There-
fore, we conclude that the total genomic content of cur-
rently identiﬁed common human CNVs is likely lower
than previous estimates that were obtained with lower-res-
olution platforms (e.g., 12% of the genome16) or based on
all DGV regions (currently, 18.8% of the genome39).
Reﬁning the Breakpoints of Human CNVs and
Mechanisms of CNV Formation
Delineation of CNV breakpoints provides precise identiﬁca-
tionof the copy-number-variable functional elements in the
Figure 1. Size Distribution of CNVs from the Database of
Genomic Variants, with Corresponding CNVs from This Study
We identified CNVs in at least one individual for 1153 of 2191 pu-
tative CNV regions annotated in the Database of Genomic Variants
(DGV) as of 30 November 2006. Size distributions for these regions
are shown in log scale, with 10-fold multiples of 1 and O10, based
on the size of each region from DGV and the estimates from our
study of the total amount of copy-number-variable sequence
within and overlapping the DGV-defined region. Our estimates
were smaller than the corresponding DGV region for 1020 of
the 1153 loci (88%) and smaller by more than 50% for 876
regions (76%).merican Journal of Human Genetics 82, 685–695, March 2008 687
Table 1. Summary of CNV-Size-Estimate Comparisons with Previous Studies
Previous CNV Study Platform or Method
Number of
Reported CNVsa
Number of CNVs
Overlapping with
CNVs from
This Study
(Proportion)b
Number of CNVs
Observed in Both
Studies with
Smaller Estimated
Size in This Study
(Proportion)
Number of CNVs
Observed in Both Studies
with Estimated Size in
This Study Less Than 50% of
the Estimated Size in
Previous Study (Proportion)
Conrad et al.14 HapMap SNP patterns 544 199 (0.37) 29 (0.15) 13 (0.07)
de Smith et al.17 Agilent oligonucleotide arrays 572 322 (0.56) 158 (0.49) 75 (0.23)
Iafrate et al.10 BAC-based aCGH 190 99 (0.52) 76 (0.77) 70 (0.71)
Locke et al.54 BAC-based aCGH 253 161 (0.64) 99 (0.61) 81 (0.50)
McCarroll et al.15 HapMap SNP patterns 495 211 (0.43) 43 (0.20) 24 (0.11)
Pinto et al.39 Affymetrix SNP arrays 774 392 (0.51) 335 (0.85) 269 (0.69)
Redon et al.16—all
HapMapc
Affymetrix SNP arrays 980 530 (0.54) 484 (0.91) 342 (0.65)
Redon et al.16—30
individualsd
Affymetrix SNP arrays 286 259 (0.91) 194 (0.75) 77 (0.30)
Redon et al.16—all
HapMapc
BAC-based aCGH 913 654 (0.72) 636 (0.97) 568 (0.87)
Redon et al.16—30
individualsd
BAC-based aCGH 479 375 (0.78) 320 (0.85) 242 (0.65)
Sebat et al.11 ROMA aCGH 80 58 (0.73) 28 (0.48) 24 (0.41)
Sharp et al.12 BAC-based aCGH 159 101 (0.64) 51 (0.50) 39 (0.39)
Simon-Sanchez et al.61 Illumina BeadChips 154 70 (0.45) 58 (0.83) 49 (0.70)
Tuzun et al.13 Fosmid end mapping 253 124 (0.49) 73 (0.59) 48 (0.39)
Wang et al.62 Illumina BeadChips 749 325 (0.43) 137 (0.42) 94 (0.29)
Wong et al.19 BAC-based aCGH 465 247 (0.53) 177 (0.72) 141 (0.57)
Zogopoulos et al.63 Affymetrix SNP arrays 273 182 (0.67) 139 (0.76) 114 (0.63)
a From CNV data in the Database of Genomic Variants as of September 2007. For studies published after our selection of CNV regions for high-density probe
coverage in our array design (based on the Database of Genomic Variants, November 2006), we have only included and analyzed their reported CNV regions
that are within the originally selected regions.
b It is important to note that different samples were used for many of these studies. Therefore, the concordance rate is expected to depend not only on the
properties and performance of these platforms and of our CNV-enriched array, but also on the sample composition and the number of samples studied. For
example, we have analyzed the data from Redon et al.16 considering (1) all 270 HapMap individuals study and (2) only the 30 individuals that were also
included in our study, and observed notably higher concordance in the latter analysis.
c Based on data from all 270 HapMap individuals.
d Based on data from only the 30 HapMap individuals included in this study. For regions in which CNVs were called in one or more of the 30 HapMap
individuals by both the Redon et al.16 500K EA platform (Affymetrix SNP arrays) and in this study, the total estimated size of all CNV regions was 50.3
Mb, based on the 500K EA results and 43.0 Mb in this study, representing a 15% reduction in size. With the same criteria, the total estimated size of
all CNV regions was 102.3 Mb, based on the Redon et al.16 WGTP platform and 68.9 Mb in this study (33% reduction).human genome, whichwill be important for the generation
and testing of hypotheses concerning the roles of CNVs in
complexdiseases, aswell as for global analyses of the proper-
ties of human CNVs (e.g., Gene Ontology analyses). More-
over, precise deﬁnitionofCNVbreakpointswill lead to abet-
terunderstandingof themechanismsofCNVformation.For
example, previous studies have observed that segmental du-
plications (SDs; low-copy repeats at least 1 kb in size with at
least 90% homology34) are enriched within and near CNVs,
suggesting nonallelic homologous recombination (NAHR)
as a likely mechanism for the genesis of these CNVs (for re-
view, see35). However, only a minority of CNVs overlap
SDs—for example, just 25% of the CNVs from the Redon
et al. study16 are associated with SDs—and this proportion
is likely to decrease as smaller CNVs are identiﬁed by plat-
forms with improved resolution.40 In addition, precise
breakpoint data are currently available for only a fraction
of the known non-SD associated CNVs (e.g.,18,41–44). There-
fore, the mechanisms underlying the formation of the
majority of human CNVs remain unknown.688 The American Journal of Human Genetics 82, 685–695, March 2With our CNV-enriched array, we were able to estimate
breakpoints to approximately 1 kb resolution (Table S1).
To evaluate the accuracy of these predictions and advance
our understanding of the mechanisms of CNV formation,
we developed a strategy for polymerase chain reaction
(PCR) ampliﬁcation and sequencing over the breakpoints
of CNVs identiﬁed in our study (excluding complex
CNVs with interindividual variation in estimated break-
points and CNVs that are associated with SDs). This strat-
egy was designed to amplify over the breakpoint regardless
of whether the CNV was actually a deletion or a tandem
duplication (because we had little a priori knowledge of
the absolute-copy-number state for each of the CNVs in
our reference individual; Figure S3). By using this ap-
proach, we successfully sequenced over the breakpoints
of 23 of 51 attempted CNVs (Figure 2; Table S8). Twenty
of 23 CNVs were sequenced in multiple individuals, with
identical breakpoints observed across all samples. Interest-
ingly, all 23 of the successfully sequenced CNVs were dele-
tions rather than duplications (i.e., unique DNA segments008
Figure 2. CNV Breakpoint Sequencing
We developed a PCR amplification and sequencing strategy (see Figure S3) for nucleotide-level resolution of CNV breakpoints.
(A) Log2 ratios for 30 HapMap samples for a CNV region on human chromosome 10 (hg17). Probes are depicted as solid circles. The log2
ratios form three distinct clusters (gain, no change, and loss relative to the reference individual NA10851). PCR primer locations are
depicted as arrows.
(B) Results of PCR amplification, with a 1.2% agarose gel with ethidium bromide staining. Amplification was successful for individuals
with no change and losses relative to the reference individual, as well as for the reference individual. Amplification was unsuccessful for
individuals with a relative gain, suggesting that the reference individual is heterozygous for a deletion in this genomic region.
(C) Chromatogram from NA18975 and comparison to the human reference genome sequence (hg17) to precisely identify the CNV break-
point. All sequenced individuals were observed to have identical breakpoints.from the human genome reference sequence were missing
from our sequenced fragments). It is not immediately clear
what accounts for this bias. Possible explanations include
one or more of the following: (1) that deletions might be
more common than duplications in the human genome,
at least for non-SD-associated CNVs, (2) that our break-
point predictions might in general have been more accu-
rate for deletion than duplication CNVs, and (3) that
many non-SD-associated duplication CNVs in the human
genome might be non-tandemly arranged (and thus not
detectable by our strategy).
Of the 23 deletions, we observed homologous nucleo-
tide sequences across the two breakpoints of the same
CNV in only two cases (9%; one each with ﬂanking LINE
and Alu/SINE elements). The lack of crossbreakpoint ho-
mology for the other 21 deletions suggests that nonhomol-
ogous end joining (NHEJ;45,46) might have been involved
in the formation of a large proportion of common humanTheCNVs, consistent with the observations made by a recent
paired-end-mapping CNV study.18 For nine of the 21
CNVs (43%) without breakpoint homology, we found in-
serted segments of between 1 and 76 bp at the breakpoints
(Table S8), which likely occurred as part of the NHEJ pro-
cess.18,47 In the cases with the two largest insertions (one
of 50 bp and one of 76 bp), the inserted sequences are ho-
mologous to a segment within the deletion but in inverted
orientation. Another deletion was found to co-occur with
a larger inversion near its 50 breakpoint (Table S8). Interest-
ingly, we observed that CNVs located on chromosome 2 at
130.3 Mb and chromosome 5 at 151.4 Mb in fact each con-
sisted of two distinct deletions, separated by relatively
small nondeleted segments (of 601 bp and 101 bp, respec-
tively). It is unclear whether each of these examples reﬂects
a single deletion event with an associated recovery of some
intervening sequence or two independent, nearby deletion
events. However, the latter scenario would be consistentAmerican Journal of Human Genetics 82, 685–695, March 2008 689
with our general observation that many previously de-
scribed CNV regions are in fact comprised of multiple,
smaller CNVs. For example, within the 1153 DGV regions
for whichwe observed at least one CNV,we recorded a total
of 2664 distinct and nonoverlapping regions of copy-num-
ber variation. Certain genomic regions might be particu-
larly prone to structural rearrangements.
To gain additional insight into the mechanisms of CNV
genesis in the human genome, we next interrogated the
sequence composition of all the estimated breakpoint
regions of our study (approximately 1 kb of sequence for
each estimated breakpoint region, between the copy-num-
ber-variable probe that deﬁnes the CNV boundary and the
adjacent non-copy-number-variable probe). We compared
these breakpoint-region sequences to a random set of
genomic sequences and to sequences constructed from
random pairs of adjacent non-CNV probes on the array
(in both cases, approximating the original size distribution
of the breakpoint-region sequences). We unexpectedly ob-
served a signiﬁcant enrichment for simple tandem repeats
within the individual CNV breakpoint-region sequences
(Figure 3). For example, 174 of our breakpoint-region se-
quences contain two or more perfect repeats of at least
30 bp, compared to 52 of the random genomic sequences
Figure 3. Enrichment for Tandem Repeats within Individual
CNV Breakpoint-Region Sequences
This figure depicts the empirical cumulative distribution of the
observed longest repeated subsequence ki (k 3 i), where k ¼ the
length of the repeated subsequence and i ¼ the number of recur-
rences within the sequence, for the sequences between the copy-
number-variable probes at CNV boundaries and the adjacent non-
copy-number-variable probes estimated to harbor breakpoints in
our study (CNV breakpoint sequences; approximately 1 kb each),
sequences from between random pairs of adjacent non-CNV probes
on the array (random interprobe sequences), and a random set of
genome-wide sequences. The random sequences were selected
such as to not alter the characteristics of the observed set of
CNV calls, in terms of lengths and proximity of the end sequences.
The graph reflects only the significant end of the distribution—the
top 100 sequences as ranked by ki. A larger proportion of CNV
breakpoint-region sequences contain long tandem repeats than
the random sequences.690 The American Journal of Human Genetics 82, 685–695, March 2[p < 1016; the hypergeometric tail HGT(N,B,n,b)48 was
computed for a universal set of N¼ 20,195 observed break-
point-region and random sequences, for B ¼ 10,115
observed breakpoint-region sequences, for n ¼ 226 total
sequences containing repeats of at least 30 bp, and for an
intersection of b ¼ 174 observed breakpoint-region se-
quences containing at least 30 bp repeats] and 77 se-
quences between random sets of probes on the array (p <
109). These sequences might lead to non-B DNA confor-
mations,49 and possibly general genomic instability. Al-
though other features thought to be involved in the forma-
tion of non-B DNA, such as (R)n, (Y)n, (RY)n, and inverted
repeats,49,50 were not found to be signiﬁcantly enriched
within our breakpoint-region sequences (p > 0.05), we
did identify a signiﬁcant enrichment of inverted repeats be-
tween the two breakpoint-region sequences of our CNVs
(Figure S4). These include many inverted Alu repeats,
which are generally depleted in the human genome.51,52
This depletion possibly reﬂects purifying selection on in-
vertedAlu insertions or the long-term tendency for these re-
gions to be lost through the ﬁxation of deletions, or both.
Discussion
There is currently little consensus regarding the true prev-
alence of CNV architectural complexity and the extent to
which this should inﬂuence the design of future disease
association studies. A subset of previously identiﬁed
CNVs has been found to be in strong linkage disequilib-
rium with ﬂanking single-nucleotide polymorphisms
(SNPs),15,16,42,53,54 implying a single origin and identical
breakpoints among individuals. Many of these simple
CNVs could be tagged by adjacent SNPs and thereby be
effectively captured by high-throughput SNP genotyping
platforms.55 In contrast, CNV loci that were formed
by multiple structural-rearrangement events (complex
CNVs) might require more direct approaches for accurate
measurement and inclusion in genome-wide disease asso-
ciation studies. Although certain previously identiﬁed
CNVs do appear to harbor some degree of complexity—as
evidenced by breakpoint variation and spatial complex-
ity,14,16,56 susceptibility to recurrent origin,57–60 and obser-
vations of relatively low linkage disequilibrium with ﬂank-
ing SNPs16,54—the relative contribution of such regions to
the total content of human genomic variation remains
unclear.
In our dataset, there were 1326 distinct genomic regions
in which CNVs were called in two or more of the 30 Hap-
Map individuals. On the basis of our high-resolution
aCGH data, 705 of these CNV regions had consistent
breakpoints (to within one probe resolution) across all var-
iant samples (Table S3); many of these CNVs are likely to be
simple in nature. For these 705 loci, we developed
a method for scoring the modality of CNVs that was
based on a t test, to identify CNVs for which the mean
log2 ratios form discrete clusters (i.e., likely reﬂecting008
Figure 4. Simple CNVs and Inference of Genotypes, Based on Discrete Log2-Ratio Clustering
For two CNV-containing genomic regions that have similar estimated breakpoints across all individuals, probe-by-probe log2 ratios are
depicted in heatmaps (see scale bar) in the upper panel (with rows representing individuals and columns representing probes ordered
by genomic position). Mean log2 ratios of the probes within the CNV are provided in the lower panel. The mean log2 ratios form discrete
clusters, letting us infer CNV genotypes. For both loci, there is one cluster with strongly negative log2 ratios, suggesting that these
individuals have homozygous deletions for this DNA segment. For the CNV on chromosome 4 at 155.5 Mb (hg17), there are three
mean log2-ratio clusters, likely reflecting zero, one, and two copies of this DNA segment. For the CNV on chromosome 12 at 130.8 Mb
there are four mean log2-ratio clusters, likely reflecting states of zero, one, two, and three copies; therefore, this CNV would be considered
to be multiallelic. Error bars represent the standard deviation (SD).distinct copy-number states; Figure 4). By using stringent
thresholds, we identiﬁed 49 CNVs with two mean log2-
ratio clusters, 186 CNVs with three clusters, and one
CNV with four distinct clusters (Table S3; depictions of
mean log2 ratios for all 236 discretely clustering CNVs
are available at the Lee Lab Website). The remaining 469
CNVs were not robustly separable into distinct clusters.
In future studies, modality analyses for such CNVs might
beneﬁt from larger sample sizes and the inclusion of addi-
tional probes within the CNV regions.
To identify and describe architecturally complex geno-
mic regions, we searched for evidence of smaller CNVs
contained within larger ones, CNVs with interindividual
breakpoint variation, or CNVs with juxtaposed gains and
losses within the same individual. Before conducting this
analysis, we eliminated the probes that had perfect
matches to multiple chromosomes or to sites more than
2 Mb away on the same chromosome. The inclusion of
such probes could result in CNV shadowing effects, or arti-
factual calling of CNVs in a particular region due to true
CNVs in homologous regions of the genome (see Table
S9). These shadowing effects could lead to false appear-The Aances of complexity. By using the remaining probes (the
proximal probe set; see Material and Methods) and a com-
bination of computational ﬁltering and manual curation,
we identiﬁed 101 CNV regions with evidence for architec-
tural complexity (Figure 5 and Figure S5; Table S10; depic-
tions of all 101 complex CNV regions are available at the
Lee Lab Website). This could be considered an underesti-
mate of CNV complexity in the human genome, given
our conservative calling approach and a sample size of 30
individuals.
It should be noted that for this analysis, we did not re-
move probes with imperfect sequence similarities to else-
where in the genome, or with perfect sequence similarities
that occurred on the same chromosome at distance of less
than 2 Mb, because this would have limited our ability to
examine tandemly arranged SDs. Therefore, shadowing
effects could still explain a subset of the 101 complex
regions. However, we believe that many of these regions
are truly architecturally complex. For example, SDs are
completely absent from 20 of these regions (including
both validated regions depicted in Figure 5 and two of
the three validated regions in Figure S5), and for many ofmerican Journal of Human Genetics 82, 685–695, March 2008 691
Figure 5. Validation of Architecturally Complex CNV Regions by qPCR
We used a series of quantitative PCR (qPCR) probes positioned across CNV regions to validate the patterns of architectural complexity
observed with our CNV-enriched array. The probe-by-probe log2 ratios depicted in the heatmaps (see scale bars) illustrate examples of
a smaller CNV inside a larger one on chromosome 4 at 162.2 Mb (A) and a CNV with immediately adjacent and variably present CNVs
(i.e., juxtaposed gain and loss CNV calls in the same individual) on chromosome 6 at 0.2 Mb (B). The relative genomic positions of
the probes are depicted with black lines, with midpoint positions (hg17) provided for selected probes (thicker lines). For each CNV,
qPCR primers were designed at intervals throughout and flanking the CNV region and tested on all individuals depicted in the heatmaps.
The qPCR results (i.e., relative copy number to the reference individual NA10851) are consistent with the aCGH results provided as log
ratio (i.e., to be on a consistent scale with the qPCR results) for each interval. Error bars represent the SD. See Table S11 for qPCR primers
and results.the remaining regions, segmental duplications cannot
fully explain the patterns of complexity. Strategies for elu-
cidating the true underlying structure of these regions will
need to be considered for future studies.
In summary, our results suggest that while the majority
of human CNVs might be simple in nature, a substantial
proportion of previously identiﬁed human CNV regions
might in fact harbor some degree of architectural complex-692 The American Journal of Human Genetics 82, 685–695, March 2ity. Speciﬁcally, approximately 8% of regions containing
CNVs in at least 2 individuals were classiﬁed as complex
on the basis of our conservative criteria. This observation
further highlights the structural instability and variation
of the human genome and has important implications
for future human genetics studies. For example, the func-
tional effects of architecturally complex CNVs might be
intricate and unexpected. Moreover, these complex CNV008
regions will be difﬁcult to incorporate into future genome-
wide disease association studies without direct ascertain-
ment and detailed characterization of their ﬁne-scale archi-
tecture.
Supplemental Data
Five ﬁgures, simple CNVs, complex CNVs, and 11 tables are avail-
able at http://www.ajhg.org/.
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